Diisopropylethylamine → 8-[(1-Acryloylpiperidin-4-yl)amino]-N-(2,6-diethylphenyl)-1-methyl-4,5-dihydro-1H-pyrazolo[4,3-h]quinazoline-3-carboxamide

HRID 81959

Reaktionsgleichung

Reaktionsgleichung von HRID 81959
Cl.[CH2:2]([C:4]1[CH:9]=[CH:8][CH:7]=[C:6]([CH2:10][CH3:11])[C:5]=1[NH:12][C:13]([C:15]1[C:19]2[CH2:20][CH2:21][C:22]3[CH:23]=[N:24][C:25]([NH:28][CH:29]4[CH2:34][CH2:33][NH:32][CH2:31][CH2:30]4)=[N:26][C:27]=3[C:18]=2[N:17]([CH3:35])[N:16]=1)=[O:14])[CH3:3].CCN(C(C)C)C(C)C.Br[CH2:46][CH2:47][C:48](Cl)=[O:49]>ClCCl>[C:48]([N:32]1[CH2:31][CH2:30][CH:29]([NH:28][C:25]2[N:24]=[CH:23][C:22]3[CH2:21][CH2:20][C:19]4[C:15]([C:13]([NH:12][C:5]5[C:4]([CH2:2][CH3:3])=[CH:9][CH:8]=[CH:7][C:6]=5[CH2:10][CH3:11])=[O:14])=[N:16][N:17]([CH3:35])[C:18]=4[C:27]=3[N:26]=2)[CH2:34][CH2:33]1)(=[O:49])[CH:47]=[CH2:46]

Komponenten

5

Versuchsvorschrift

To a solution of N-(2,6-diethylphenyl)-1-methyl-8-(piperidin-4-ylamino)-4,5-dihydro-1H-pyrazolo[4,3-h]quinazoline-3-carboxamide hydrochloride (40 mg, 0.075 mmol) in dichloromethane (1 mL) at 0° C., DIPEA (0.4 mL, 2.2 mmol), and 3-bromopropionyl chloride (0.023 mL, 0.226 mmol) were added. The mixture was then stirred at room temperature for 3 h. Solvent evaporated to dryness and the crude solid was purified by flash chromatography on silica gel (eluant: dichloromethane/methanol: 9/1) to 73 mg of the title compound. (75% yield)

Aufarbeitung

  1. customSolvent evaporated to dryness
  2. customthe crude solid was purified by flash chromatography on silica gel (eluant: dichloromethane/methanol: 9/1) to 73 mg of the title compound

Quellen und Nachweise

ORD-Eintrag
ord-073bfe9d51044ca7b527444e4751927e
Quelldatensatz
uspto-grants-2014_09
Patentnummer
US08846701B2

Verknüpfte Notizen

Wird geladen…